Senestech (NASDAQ:SNES – Get Free Report) is expected to be releasing its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect Senestech to post earnings of ($0.30) per share and revenue of $0.7760 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 12, 2026 at 4:00 PM ET.
Senestech Stock Up 2.8%
Senestech stock opened at $2.19 on Wednesday. Senestech has a one year low of $1.30 and a one year high of $6.24. The stock has a fifty day moving average of $2.10 and a 200 day moving average of $3.16. The company has a debt-to-equity ratio of 0.01, a quick ratio of 14.73 and a current ratio of 15.75. The stock has a market cap of $11.43 million, a PE ratio of -0.60 and a beta of 0.15.
Insider Transactions at Senestech
In related news, major shareholder Glenbrook Capital Management purchased 34,613 shares of the business’s stock in a transaction on Thursday, February 19th. The stock was acquired at an average price of $2.40 per share, with a total value of $83,071.20. Following the completion of the acquisition, the insider owned 704,211 shares of the company’s stock, valued at approximately $1,690,106.40. This trade represents a 5.17% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders bought a total of 173,954 shares of company stock worth $367,303 over the last three months. Insiders own 5.29% of the company’s stock.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Senestech currently has a consensus rating of “Hold”.
Check Out Our Latest Report on Senestech
Senestech Company Profile
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Featured Stories
- Five stocks we like better than Senestech
- New Copper-Rich “Kraken” Zone Discovered
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Trade this between 9:30 and 10:45 am EST
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
